Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Cossart (2004)
Human Parvovirus B19American Journal of Transplantation, 4
N. Ahsan, M. Holman, C. Gocke, J. Groff, H. Yang (1997)
Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.Clinical transplantation, 11 4
D. Arnold, P. Neame, Ralph Meyer, P. Soamboonsrup, K. Luinstra, P. O’Hoski, J. Garner, R. Foley (2005)
Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infectionTransfusion, 45
I. Thomas, M. Giambattista, C. Gérard, E. Mathys, V. Hougardy, B. Latour, T. Branckaert, Ruth Laub (2003)
Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non‐structural viral proteinsVox Sanguinis, 84
P. Mortimer, N. Luban, J. Kelleher, B. Cohen (1983)
TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 322
B. Schneider, M. Becker, H. Brackmann, A. Eis-Hübinger (2004)
Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2Thrombosis and Haemostasis, 92
E. Mylonakis, B. Dickinson, M. Mileno, T. Flanigan, F. Schiffman, A. Mega, J. Rich (1999)
Persistent parvovirus B19 related anemia of seven years' duration in an HIV‐infected patient: Complete remission associated with highly active antiretroviral therapyAmerican Journal of Hematology, 60
A. Zanella, F. Rossi, C. Cesana, A. Foresti, F. Nador, A. Binda, G. Lunghi, M. Cappellini, M. Furione, G. Sirchia (1995)
Transfusion‐transmitted human parvovirus B19 infection in a thalassemic patientTransfusion, 35
F. Hayakawa, K. Imada, M. Towatari, H. Saito (2002)
Life‐threatening human parvovirus B19 infection transmitted by intravenous immune globulinBritish Journal of Haematology, 118
J. Blümel, I. Schmidt, W. Effenberger, H. Seitz, H. Willkommen, H. Brackmann, J. Löwer, A. Eis-Hübinger (2002)
Parvovirus B19 transmission by heat‐treated clotting factor concentratesTransfusion, 42
E. Santagostino, P. Mannucci, A. Gringeri, A. Azzi, M. Morfini, R. Musso, R. Santoro, M. Schiavoni (1997)
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.Transfusion, 37 5
M. Kawamura, M. Sawafuji, Masazumi Watanabe, H. Horinouchi, Koichi Kobayashi (2002)
Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery.The Annals of thoracic surgery, 73 4
K. Brown, N. Young, B. Alving, L. Barbosa (2001)
Parvovirus B19: implications for transfusion medicine. Summary of a workshopTransfusion, 41
L. Liefeldt, M. Buhl, B. Schweickert, E. Engelmann, O. Sezer, Peter Laschinski, L. Preuschof, H. Neumayer (2002)
Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 17 10
Parvovirus B 19 : implications for
A. Plentz, J. Hahn, E. Holler, W. Jilg, S. Modrow (2004)
Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 31 1
E. Heegaard, Bodil Petersen (2000)
Parvovirus B19 transmitted by bone marrowBritish Journal of Haematology, 111
A. Knöll, F. Louwen, B. Kochanowski, A. Plentz, J. Stüssel, K. Beckenlehner, W. Jilg, S. Modrow (2002)
Parvovirus B19 infection in pregnancy: Quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR)Journal of Medical Virology, 67
G. Gallinella, E. Moretti, G. Nardi, E. Zuffi, F. Bonvicini, E. Bucci, M. Musiani, M. Zerbini (2002)
Analysis of B19 virus contamination in plasma pools for manufacturing, by using a competitive polymerase chain reaction assayVox Sanguinis, 83
N. Frickhofen, N. Young (1989)
Persistent parvovirus B19 infections in humans.Microbial pathogenesis, 7 5
R. Cavallo, C. Merlino, D. Re, C. Bollero, M. Bergallo, David Lembo, Tiziana Musso, G. Leonardi, G. Segoloni, A. Ponzi (2003)
B19 virus infection in renal transplant recipients.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 26 3
D. Geetha, James Zachary, Helen Baldado, J. Kronz, E. Kraus (2000)
Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literatureClinical Transplantation, 14
G. Kurtzman, B. Cohen, A. Field, R. Oseas, R. Blaese, N. Young (1989)
Immune response to B19 parvovirus and an antibody defect in persistent viral infection.The Journal of clinical investigation, 84 4
H. Lehmann, A. Knöll, R. Küster, S. Modrow (2003)
Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.Arthritis and rheumatism, 48 6
G. Asma, R. Bergh, J. Vossen (1987)
Regeneration of TdT+, pre-B, and B cells in bone marrow after allogeneic bone marrow transplantation.Transplantation, 43 6
Y. Yoto, T. Kudoh, K. Haseyama, N. Suzuki, Takanori Oda, T. Katoh, Tsuneo Takahashi, Sadami Sekiguchi, Shunzo Chiba (1995)
Incidence of human parvovirus B19 DNA detection in blood donorsBritish Journal of Haematology, 91
D. Candotti, N. Etiz, Armen Parsyan, J. Allain (2004)
Identification and Characterization of Persistent Human Erythrovirus Infection in Blood Donor SamplesJournal of Virology, 78
PD Schleuning, Dr. Jäger, PD Holler, Dr. Hill, Dr. Thomssen, PD Denzlinger, Dr. Lorenz, Dr. Ledderose, Prof. Wilmanns, Prof. Kolb (1999)
Human parvovirus B19-associated disease in bone marrow transplantationInfection, 27
G. Kurtzman, N. Frickhofen, J. Kimball, D. Jenkins, A. Nienhuis, N. Young (1989)
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.The New England journal of medicine, 321 8
K. Groeneveld, J. Noordaa (2003)
Blood products and parvovirus B19.The Netherlands journal of medicine, 61 5
O. Corsi, A. Azzi, M. Morfini, R. Fanci, P. Ferrini (1988)
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesJournal of Medical Virology, 25
L. Liefeldt, A. Plentz, B. Klempa, O. Kershaw, A. Endres, U. Raab, H. Neumayer, H. Meisel, S. Modrow (2005)
Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real‐time PCR for simultaneous detection of genotypes 1 to 3Journal of Medical Virology, 75
P. Cassinotti, G. Burtonboy, M. Fopp, G. Siegl (1997)
Evidence for persistence of human parvovirus B19 DNA in bone marrowJournal of Medical Virology, 53
N. Frickhofen, J. Abkowitz, M. Safford, J. Berry, J. Antunez-de-Mayolo, A. Astrow, Robert Cohen, I. Halperin, L. King, D. Mintzer, B. Cohen, N. Young (1990)
Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.Annals of internal medicine, 113 12
A. Yango, Paul Morrissey, R. Gohh, A. Wahbeh (2002)
Donor‐transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunctionTransplant Infectious Disease, 4
J. Jordan, B. Tiangco, J. Kiss, W. Koch (1998)
Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion RecipientsVox Sanguinis, 75
M. Koppelman, H. Cuypers, T. Emrich, H. Zaaijer (2004)
Quantitative real‐time detection of parvovirus B19 DNA in plasmaTransfusion, 44
D. Erdman, B. Anderson, T. Török, T. Finkel, L. Anderson (1997)
Possible transmission of parvovirus B19 from intravenous immune globulinJournal of Medical Virology, 53
Heegaard Heegaard, Brown Brown (2002)
Human parvovirus B19Clin Microbiol Rev, 15
Ulrike Koenigbauer, T. Eastlund, J. Day (2000)
Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent‐treated pooled plasmaTransfusion, 40
M. Hino, O. Ishiko, K. Honda, T. Yamane, K. Ohta, T. Takubo, N. Tatsumi (2000)
Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgeryBritish Journal of Haematology, 108
S. Marchand, G. Tchernia, C. Hiesse, G. Tertian, J. Cartron, F. Kriaa, S. Boubenider, C. Goupy, D. Lecointe, B. Charpentier (1999)
Human parvovirus B19 infection in organ transplant recipientsClinical Transplantation, 13
BACKGROUND: Patients with hematologic malignancies often require blood products, and parvovirus B19 is known to be transmitted by this route. Primary infection with parvovirus B19 shows a wide variety of disease manifestation. In immunocompromised patients, symptoms are severe and viral clearance is delayed or missing. STUDY DESIGN AND METHODS: A total of 2123 blood products given to all patients of a hematologic ward over a period of 6 months were retrospectively examined for the presence of parvovirus B19 DNA by an in‐house real‐time polymerase chain reaction (PCR; TaqMan). Patients who had received B19 DNA–positive blood products were further investigated serologically and by PCR for the presence of parvovirus B19 antibodies and DNA. RESULTS: Twenty‐one (1%) of 2123 blood products tested positive for the presence of B19 DNA (2% of pooled products, 0.7% of single‐donor products, and 17.6% of allogeneic peripheral blood progenitor cells), the median viral load was 700 genome equivalents per mL. During the study period, 114 patients were treated on the ward, and 14 (12%) of them received B19 DNA–positive blood components. None of them developed symptoms of an acute B19 infection, although one had a short low‐level viremia. CONCLUSIONS: Although B19 DNA was detected in 1 percent of blood products given to hematologic patients, the exposure of 12 percent of patients did not result in symptomatic infections.
Transfusion – Wiley
Published: Nov 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.